Tag: I-Mab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to I-Mab

$0.19 EPS Expected for I-Mab (NASDAQ:IMAB) This Quarter

Added to Collection on: 2021-04-13 06:11:15

Tags for this article:

Finance

Financial markets

Money

Click the tags to see associated articles and topics

View Article Details

I-Mab (NASDAQ:IMAB) Short Interest Up 46.3% in March

Added to Collection on: 2021-04-17 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

TJ-CD4B Aims to Expand the Bispecific Antibody Portfolio as Phase 1 Trial Kicks Off

Added to Collection on: 2021-04-27 16:09:21

Tags for this article:

Bispecific monoclonal antibody

Antigen

I-Mab

Click the tags to see associated articles and topics

View Article Details

I-Mab Announces Upcoming Participation at May Conferences

Added to Collection on: 2021-04-29 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

I-Mab Honored with Top Rankings by Institutional Investor

Added to Collection on: 2021-06-30 12:00:00

Tags for this article:

Biodiversity

Biomes

Environment

Man and the Biosphere Programme

Click the tags to see associated articles and topics

View Article Details

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

Added to Collection on: 2021-07-01 12:00:00

Tags for this article:

Clusters of differentiation

Cancer treatments

Monoclonal antibody

CD137

Programmed cell death protein 1

Bispecific monoclonal antibody

Click the tags to see associated articles and topics

View Article Details

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs ...

Added to Collection on: 2021-07-01 12:00:00

Tags for this article:

Life Sciences

Health care

Regenerative biomedicine

Pharmaceutical companies

Vanda Pharmaceuticals Inc.

Avid Bioservices Inc.

Codex DNA Inc.

Beam Therapeutics Inc

Century Therapeutics Inc.

cyteir therapeutics, inc

I-Mab

Intellia Therapeutics Inc

Ambrx Biopharma Inc.

Graphite Bio Inc.

Zoetis Inc.

Harvard Bioscience Inc.

Moderna, Inc.

Verve Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details

Relevance of trade secret ownership for misappropriation: I-Mab Biopharma v. Inhibrx Inc.

Added to Collection on: 2024-12-24 00:04:27

Tags for this article:

Secrecy

Intellectual property law

Trade secrets

Defend Trade Secrets Act

Man and the Biosphere Programme

Click the tags to see associated articles and topics

View Article Details

Relevance of Trade Secret Ownership for Misappropriation: I-Mab Biopharma v. Inhibrx Inc.

Added to Collection on: 2024-12-24 20:35:21

Tags for this article:

Secrecy

Intellectual property law

Trade secrets

Defend Trade Secrets Act

Man and the Biosphere Programme

Click the tags to see associated articles and topics

View Article Details

Wall Street Zen Upgrades I-Mab (NASDAQ:IMAB) to Buy - Defense World

Added to Collection on: 2025-10-11 11:47:29

Tags for this article:

Man and the Biosphere Programme

I-Mab

Click the tags to see associated articles and topics

View Article Details

Tag: I-Mab

Recent Related Articles to I-Mab

$0.19 EPS Expected for I-Mab (NASDAQ:IMAB) This Quarter

I-Mab (NASDAQ:IMAB) Short Interest Up 46.3% in March

TJ-CD4B Aims to Expand the Bispecific Antibody Portfolio as Phase 1 Trial Kicks Off

I-Mab Announces Upcoming Participation at May Conferences

I-Mab Honored with Top Rankings by Institutional Investor

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs ...

Relevance of trade secret ownership for misappropriation: I-Mab Biopharma v. Inhibrx Inc.

Relevance of Trade Secret Ownership for Misappropriation: I-Mab Biopharma v. Inhibrx Inc.

Wall Street Zen Upgrades I-Mab (NASDAQ:IMAB) to Buy - Defense World

Create dashboard for Tag: I-Mab